{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T01:17:41Z","timestamp":1794964661160,"version":"4.9.1"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T00:00:00Z","timestamp":1452816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Free Radical Biology and Medicine"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.freeradbiomed.2016.01.008","type":"journal-article","created":{"date-parts":[[2016,1,19]],"date-time":"2016-01-19T03:05:35Z","timestamp":1453172735000},"page":"100-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1"],"prefix":"10.1016","volume":"92","author":[{"given":"H\u00e9l\u00e8ne","family":"Choquet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Trapani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Goitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0850-7186","authenticated-orcid":false,"given":"Lorenza","family":"Trabalzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Akers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4023-1909","authenticated-orcid":false,"given":"Marco","family":"Fontanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blaine L.","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie A.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmila","family":"Pawlikowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saverio Francesco","family":"Retta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.01.008_bib1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/jnnp.71.2.188","article-title":"Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations","volume":"71","author":"Clatterbuck","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.01.008_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1227\/01.neu.0000440729.59133.c9","article-title":"Pathobiology of human cerebrovascular malformations: basic mechanisms and clinical relevance","volume":"55","author":"Gault","year":"2004","journal-title":"Neurosurgery"},{"issue":"12","key":"10.1016\/j.freeradbiomed.2016.01.008_bib3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nrneurol.2009.177","article-title":"Cavernous malformations: natural history, diagnosis and treatment","volume":"5","author":"Batra","year":"2009","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.01.008_bib4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3171\/2011.8.JNS101241","article-title":"Cerebral cavernous malformations: from genes to proteins to disease","volume":"116","author":"Cavalcanti","year":"2012","journal-title":"J. Neurosurg."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2016.01.008_bib5","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/ana.20947","article-title":"Genotype\u2013phenotype correlations in cerebral cavernous malformations patients","volume":"60","author":"Denier","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.freeradbiomed.2016.01.008_bib6","series-title":"Cavernous Malformations of the Nervous System","author":"Rigamonti","year":"2011"},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.01.008_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000356839","article-title":"Association of cardiovascular risk factors with disease severity in cerebral cavernous malformation type 1 subjects with the common Hispanic mutation","volume":"37","author":"Choquet","year":"2014","journal-title":"Cerebrovasc. Dis."},{"issue":"6","key":"10.1016\/j.freeradbiomed.2016.01.008_bib8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1159\/000369200","article-title":"Polymorphisms in inflammatory and immune response genes associated with cerebral cavernous malformation type 1 severity","volume":"38","author":"Choquet","year":"2014","journal-title":"Cerebrovasc. Dis."},{"issue":"3\u20134","key":"10.1016\/j.freeradbiomed.2016.01.008_bib9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1242\/dmm.001263","article-title":"Tissue-specific conditional CCM2 knockout mice establish the essential role of endothelial CCM2 in angiogenesis: implications for human cerebral cavernous malformations","volume":"2","author":"Boulday","year":"2009","journal-title":"Dis. Models Mech."},{"issue":"116","key":"10.1016\/j.freeradbiomed.2016.01.008_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2000722","article-title":"Stabilization of VEGFR2 signaling by cerebral cavernous malformation 3 is critical for vascular development","volume":"3","author":"He","year":"2010","journal-title":"Sci. Signal."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.01.008_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nm.1911","article-title":"The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases","volume":"15","author":"Whitehead","year":"2009","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.freeradbiomed.2016.01.008_bib12","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1242\/dev.01036","article-title":"CCM1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations","volume":"131","author":"Whitehead","year":"2004","journal-title":"Development"},{"issue":"8","key":"10.1016\/j.freeradbiomed.2016.01.008_bib13","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1172\/JCI39679","article-title":"CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations","volume":"120","author":"Zheng","year":"2010","journal-title":"J. Clin. Investig."},{"issue":"9","key":"10.1016\/j.freeradbiomed.2016.01.008_bib14","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1084\/jem.20110571","article-title":"Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice","volume":"208","author":"Boulday","year":"2011","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2016.01.008_bib15","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.molmed.2013.02.004","article-title":"Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis","volume":"19","author":"Fischer","year":"2013","journal-title":"Trends Mol. Med."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.01.008_bib16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/CIRCULATIONAHA.114.010403","article-title":"Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation","volume":"131","author":"Gibson","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.freeradbiomed.2016.01.008_bib17","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2741\/3816","article-title":"Oxidative stress and endothelial dysfunction in cerebrovascular disease","volume":"16","author":"Chrissobolis","year":"2011","journal-title":"Front Biosci. (Landmark Ed.)"},{"key":"10.1016\/j.freeradbiomed.2016.01.008_bib18","doi-asserted-by":"crossref","first-page":"807682","DOI":"10.1155\/2012\/807682","article-title":"Molecular crosstalk between integrins and cadherins: do reactive oxygen species set the talk?","volume":"2012","author":"Goitre","year":"2012","journal-title":"J. Signal. Transduct."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2016.01.008_bib19","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.bbadis.2011.12.009","article-title":"Oxidative stress and cerebral endothelial cells: regulation of the blood\u2013brain-barrier and antioxidant based interventions","volume":"1822","author":"Freeman","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.freeradbiomed.2016.01.008_bib20","doi-asserted-by":"crossref","first-page":"H1566","DOI":"10.1152\/ajpheart.01310.2010","article-title":"Protecting against vascular disease in brain","volume":"300","author":"Faraci","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.freeradbiomed.2016.01.008_bib21","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1089\/ars.2011.3999","article-title":"Superoxide dismutases: role in redox signaling, vascular function, and diseases","volume":"15","author":"Fukai","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.freeradbiomed.2016.01.008_bib22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.freeradbiomed.2013.11.020","article-title":"KRIT1 loss of function causes a ROS-dependent upregulation of c-Jun","volume":"68","author":"Goitre","year":"2014","journal-title":"Free Radic Biol Med."},{"issue":"6","key":"10.1016\/j.freeradbiomed.2016.01.008_bib23","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1089\/ars.2008.2333","article-title":"Compartmentalization of redox signaling through NADPH oxidase-derived ROS","volume":"11","author":"Ushio-Fukai","year":"2009","journal-title":"Antioxid. Redox Signal."},{"issue":"7","key":"10.1016\/j.freeradbiomed.2016.01.008_bib24","doi-asserted-by":"crossref","first-page":"e11786","DOI":"10.1371\/journal.pone.0011786","article-title":"KRIT1 regulates the homeostasis of intracellular reactive oxygen species","volume":"5","author":"Goitre","year":"2010","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.freeradbiomed.2016.01.008_bib25","doi-asserted-by":"crossref","first-page":"11556","DOI":"10.1074\/jbc.M111.320259","article-title":"Adaptor protein cerebral cavernous malformation 3 (CCM3) mediates phosphorylation of the cytoskeletal proteins ezrin\/radixin\/moesin by mammalian Ste20-4 to protect cells from oxidative stress","volume":"287","author":"Fidalgo","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.01.008_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/biof.1197","article-title":"Evaluation of the bioactive properties of avenanthramide analogs produced in recombinant yeast","volume":"41","author":"Moglia","year":"2015","journal-title":"Biofactors"},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.01.008_bib27","first-page":"286","article-title":"Proteomic analysis reveals KRIT1 as a modulator for the antioxidant effects of valproic acid in human bone-marrow mesenchymal stromal cells","volume":"38","author":"Jung","year":"2015","journal-title":"Drug\u00a0Chem. Toxicol."},{"issue":"11","key":"10.1016\/j.freeradbiomed.2016.01.008_bib28","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.15252\/emmm.201505316","article-title":"Defective autophagy is a key feature of cerebral cavernous malformations","volume":"7","author":"Marchi","year":"2015","journal-title":"EMBO Mol. Med."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.01.008_bib29","first-page":"201","article-title":"Cerebral cavernous malformation (CCM) disease: from monogenic forms to genetic susceptibility factors","volume":"59","author":"Trapani","year":"2015","journal-title":"J. Neurosurg. Sci."},{"issue":"15","key":"10.1016\/j.freeradbiomed.2016.01.008_bib30","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1161\/01.CIR.102.15.1744","article-title":"Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis","volume":"102","author":"Guzik","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.freeradbiomed.2016.01.008_bib31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1469-1809.2012.00731.x","article-title":"Combined polymorphisms in oxidative stress genes predict coronary artery disease and oxidative stress in coronary angiography patients","volume":"76","author":"Heslop","year":"2012","journal-title":"Ann. Hum. Genet."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.01.008_bib32","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.taap.2009.11.028","article-title":"Oxidative stress and oxidative damage in chemical carcinogenesis","volume":"254","author":"Klaunig","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.freeradbiomed.2016.01.008_bib33","doi-asserted-by":"crossref","unstructured":"L. Lyrenas, E. Wincent, L. Forsberg, U. De Faire, R. Morgenstern, The potential impact of polymorphism on oxidative stress status, in: Redox-Genome Interactions in Health and Disease, CRC Press, 2003.","DOI":"10.1201\/9780203912874.ch10"},{"issue":"7\u20138","key":"10.1016\/j.freeradbiomed.2016.01.008_bib34","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10528-009-9252-4","article-title":"Genetic polymorphisms of cytochrome p450 and matrix metalloproteinase in chronic obstructive pulmonary disease","volume":"47","author":"Cheng","year":"2009","journal-title":"Biochem. Genet."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.01.008_bib35","first-page":"27","article-title":"Oxidative stress in chronic obstructive pulmonary disease: a lung and systemic process","volume":"20","author":"van Eeden","year":"2013","journal-title":"Can. Respir. J."},{"issue":"1612","key":"10.1016\/j.freeradbiomed.2016.01.008_bib36","doi-asserted-by":"crossref","first-page":"20120431","DOI":"10.1098\/rstb.2012.0431","article-title":"Human cytochromes P450 in health and disease","volume":"368","author":"Nebert","year":"2013","journal-title":"Philos. Trans. R. Soc. Lond. B: Biol. Sci."},{"issue":"12","key":"10.1016\/j.freeradbiomed.2016.01.008_bib37","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/nrc2015","article-title":"The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis","volume":"6","author":"Nebert","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.01.008_bib38","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.taap.2004.01.018","article-title":"Mechanisms that regulate production of reactive oxygen species by cytochrome P450","volume":"199","author":"Zangar","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.01.008_bib39","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pharmthera.2014.05.011","article-title":"Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders","volume":"144","author":"Shahabi","year":"2014","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.01.008_bib40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/1389200013338513","article-title":"Cytochrome P450 in the brain; a review","volume":"2","author":"Hedlund","year":"2001","journal-title":"Curr. Drug Metab."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.01.008_bib41","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.pharmthera.2006.11.005","article-title":"Cytochrome P450-catalyzed pathways in human brain: metabolism meets pharmacology or old drugs with new mechanism of action?","volume":"113","author":"Haining","year":"2007","journal-title":"Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.freeradbiomed.2016.01.008_bib42","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/j.1528-1167.2009.02428.x","article-title":"Pattern of P450 expression at the human blood\u2013brain barrier: roles of epileptic condition and laminar flow","volume":"51","author":"Ghosh","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.freeradbiomed.2016.01.008_bib43","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1017\/S1462399411001773","article-title":"Cytochrome P450 eicosanoids and cerebral vascular function","volume":"13","author":"Imig","year":"2011","journal-title":"Expert Rev. Mol. Med."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.01.008_bib44","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/jcbfm.2014.195","article-title":"Genetic markers in the EET metabolic pathway are associated with outcomes in patients with aneurysmal subarachnoid hemorrhage","volume":"35","author":"Donnelly","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"6","key":"10.1016\/j.freeradbiomed.2016.01.008_bib45","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2174\/15701611113116660153","article-title":"Endogenous events modulating myogenic regulation of cerebrovascular function","volume":"12","author":"Gebremedhin","year":"2014","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.freeradbiomed.2016.01.008_bib46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-2350-15-83","article-title":"Association between genetic polymorphisms of cytochrome P450 2C19 and the risk of cerebral ischemic stroke in Chinese","volume":"15","author":"Gu","year":"2014","journal-title":"BMC Med. Genet."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2016.01.008_bib47","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/FPC.0b013e32809913ea","article-title":"CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) study","volume":"17","author":"Lee","year":"2007","journal-title":"Pharmacogenet. Genom."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.01.008_bib48","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.01.008_bib49","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1471-4159.2006.04393.x","article-title":"Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction","volume":"101","author":"Haorah","year":"2007","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2016.01.008_bib50","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/01.RES.0000013290.12884.A3","article-title":"Matrix metalloproteinases: regulation and dysregulation in the failing heart","volume":"90","author":"Spinale","year":"2002","journal-title":"Circ. Res."},{"issue":"24","key":"10.1016\/j.freeradbiomed.2016.01.008_bib51","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.ehj.2003.09.022","article-title":"Correlation of oxidative stress with activity of matrix metalloproteinase in patients with coronary artery disease. Possible role for left ventricular remodelling","volume":"24","author":"Kameda","year":"2003","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.01.008_bib52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ana.21710","article-title":"Soluble endoglin modulates aberrant cerebral vascular remodeling","volume":"66","author":"Chen","year":"2009","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.freeradbiomed.2016.01.008_bib53","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/01.WCB.0000135593.05952.DE","article-title":"Mmp-9 deficiency enhances collagenase-induced intracerebral hemorrhage and brain injury in mutant mice","volume":"24","author":"Tang","year":"2004","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.01.008_bib54","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/STROKEAHA.107.488189","article-title":"Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study","volume":"39","author":"Kelly","year":"2008","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.freeradbiomed.2016.01.008_bib55","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1111\/j.1471-4159.2009.06096.x","article-title":"Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice","volume":"109","author":"Garcia-Alloza","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.freeradbiomed.2016.01.008_bib56","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.freeradbiomed.2015.06.002","article-title":"Signaling and stress: the redox landscape in NOS2 biology","volume":"87","author":"Thomas","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.01.008_bib57","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/bbrc.1999.1721","article-title":"Genetic analysis of MMP3, MMP9, and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms","volume":"265","author":"Yoon","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.01.008_bib58","doi-asserted-by":"crossref","first-page":"e57958","DOI":"10.1371\/journal.pone.0057958","article-title":"Allelic variation of the MMP3 promoter affects transcription activity through the transcription factor C-MYB in human brain arteriovenous malformations","volume":"8","author":"Huai","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.freeradbiomed.2016.01.008_bib59","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jocn.2011.09.036","article-title":"The rs9509 polymorphism of MMP-9 is associated with risk of hemorrhage in brain arteriovenous malformations","volume":"19","author":"Sun","year":"2012","journal-title":"J. Clin. Neurosci."},{"issue":"12","key":"10.1016\/j.freeradbiomed.2016.01.008_bib60","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jocn.2010.04.023","article-title":"The rs522616 polymorphism in the matrix metalloproteinase-3 (MMP-3) gene is associated with sporadic brain arteriovenous malformation in a Chinese population","volume":"17","author":"Zhao","year":"2010","journal-title":"J. Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.01.008_bib61","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0735-1097(02)01909-5","article-title":"Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease","volume":"40","author":"Lamblin","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.freeradbiomed.2016.01.008_bib62","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1159\/000319893","article-title":"Association of a functional polymorphism in the MMP-3 gene with Moyamoya Disease in the Chinese Han population","volume":"30","author":"Li","year":"2010","journal-title":"Cerebrovasc. Dis."},{"issue":"12","key":"10.1016\/j.freeradbiomed.2016.01.008_bib63","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1161\/STROKEAHA.108.515544","article-title":"Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Angioma Alliance Scientific Advisory Board","volume":"39","author":"Al-Shahi Salman","year":"2008","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.01.008_bib64","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ygeno.2011.04.005","article-title":"Next generation genome-wide association tool: design and coverage of a high-throughput European-optimized SNP array","volume":"98","author":"Hoffmann","year":"2011","journal-title":"Genomics"},{"issue":"4","key":"10.1016\/j.freeradbiomed.2016.01.008_bib65","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000341686","article-title":"Matrix metalloproteinases in human spontaneous intracerebral hemorrhage: an update","volume":"34","author":"Florczak-Rzepka","year":"2012","journal-title":"Cerebrovasc. Dis."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.01.008_bib66","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.7314\/APJCP.2014.15.3.1085","article-title":"Matrix metalloproteinases and cancer-roles in threat and therapy","volume":"15","author":"Yadav","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"10","key":"10.1016\/j.freeradbiomed.2016.01.008_bib67","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2215\/CJN.01500210","article-title":"Functional polymorphisms in matrix metalloproteinases-1,-3,-9 are associated with arteriovenous fistula patency in hemodialysis patients","volume":"5","author":"Lin","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.freeradbiomed.2016.01.008_bib68","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.11.002","article-title":"White matter hyperintensity volume correlates with matrix metalloproteinase-2 in acute ischemic stroke","volume":"23","author":"Corbin","year":"2014","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"20","key":"10.1016\/j.freeradbiomed.2016.01.008_bib69","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1136\/heartjnl-2012-302085","article-title":"Matrix metalloproteinase family gene polymorphisms and risk for coronary artery disease: systematic review and meta-analysis","volume":"98","author":"Niu","year":"2012","journal-title":"Heart"},{"issue":"9","key":"10.1016\/j.freeradbiomed.2016.01.008_bib70","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2007-8-9-r183","article-title":"The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists","volume":"8","author":"Huang","year":"2007","journal-title":"Genome Biol."},{"issue":"12","key":"10.1016\/j.freeradbiomed.2016.01.008_bib71","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.tips.2011.08.005","article-title":"Cytochrome P450 enzymes in the brain: emerging evidence of biological significance","volume":"32","author":"Ferguson","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.01.008_bib72","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.pharmthera.2006.03.008","article-title":"Cytochrome P450 4F subfamily: at the crossroads of eicosanoid and drug metabolism","volume":"112","author":"Kalsotra","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.freeradbiomed.2016.01.008_bib73","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/bs.apha.2015.03.005","article-title":"Role of cytochrome P450s in inflammation","volume":"74","author":"Christmas","year":"2015","journal-title":"Adv. Pharmacol."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.01.008_bib74","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcp.2011.03.025","article-title":"Cytochrome P4504f, a potential therapeutic target limiting neuroinflammation","volume":"82","author":"Sehgal","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2016.01.008_bib75","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/sj.jcbfm.9600205","article-title":"Induction of prostacyclin\/PGI2 synthase expression after cerebral ischemia\u2013reperfusion","volume":"26","author":"Fang","year":"2006","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.01.008_bib76","first-page":"157","article-title":"Prostacyclin synthase gene: genetic polymorphisms and prevention of some cardiovascular diseases","volume":"3","author":"Nakayama","year":"2005","journal-title":"Curr. Med. Chem. Cardiovasc. Hematol. Agents"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.01.008_bib77","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1161\/hs0202.102732","article-title":"17Beta-estradiol increases rat cerebrovascular prostacyclin synthesis by elevating cyclooxygenase-1 and prostacyclin synthase","volume":"33","author":"Ospina","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.freeradbiomed.2016.01.008_bib78","doi-asserted-by":"crossref","DOI":"10.1165\/rcmb.2014-0376OC","article-title":"KRIT1 mediates prostacyclin-induced protection against lung vascular permeability induced by excessive mechanical forces and TRAP6","author":"Meliton","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"8","key":"10.1016\/j.freeradbiomed.2016.01.008_bib79","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1440-1681.2007.04683.x","article-title":"Cerebrovascular effects of oestrogen: multiplicity of action","volume":"34","author":"Duckles","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2016.01.008_bib80","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1152\/japplphysiol.01095.2005","article-title":"Influence of sex steroid hormones on cerebrovascular function","volume":"101","author":"Krause","year":"2006","journal-title":"J. Appl. Physiol.\u00a0(1985)"},{"issue":"4","key":"10.1016\/j.freeradbiomed.2016.01.008_bib81","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1124\/mol.105.014662","article-title":"Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels","volume":"68","author":"Stirone","year":"2005","journal-title":"Mol. Pharmacol."},{"issue":"9","key":"10.1016\/j.freeradbiomed.2016.01.008_bib82","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1742-4658.2011.08432.x","article-title":"Cytochrome P450s in the synthesis of cholesterol and bile acids-from mouse models to human diseases","volume":"279","author":"Lorbek","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.freeradbiomed.2016.01.008_bib83","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.redox.2012.12.001","article-title":"Oxysterols in the pathogenesis of major chronic diseases","volume":"1","author":"Poli","year":"2013","journal-title":"Redox Biol."},{"issue":"25","key":"10.1016\/j.freeradbiomed.2016.01.008_bib84","doi-asserted-by":"crossref","first-page":"22980","DOI":"10.1074\/jbc.M303415200","article-title":"Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover","volume":"278","author":"Lund","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2016.01.008_bib85","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1146\/annurev.biochem.78.072407.103859","article-title":"Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain","volume":"78","author":"Russell","year":"2009","journal-title":"Annu. Rev. Biochem."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.01.008_bib86","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3233\/JAD-2012-111460","article-title":"Markers of cholesterol metabolism in the brain show stronger associations with cerebrovascular disease than Alzheimer\u2019s disease","volume":"30","author":"Hughes","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.freeradbiomed.2016.01.008_bib87","first-page":"119","article-title":"Metabolism of vitamin D3 by cytochromes P450","volume":"10","author":"Sakaki","year":"2005","journal-title":"Front. Biosci."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.01.008_bib88","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbapap.2010.06.022","article-title":"Cytochromes P450 are essential players in the vitamin D signaling system","volume":"1814","author":"Schuster","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.freeradbiomed.2016.01.008_bib89","doi-asserted-by":"crossref","unstructured":"H.J. Ting, Y.F. Lee, Vitamin D and oxidative stress, in: A.F. Gombart (Ed.), Vitamin D: Oxidative Stress, Immunity, and Aging, CRC Press, 2012, pp. 131\u2013150","DOI":"10.1201\/b13714-8"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.01.008_bib90","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1161\/CIRCRESAHA.113.301241","article-title":"Vitamin D and cardiovascular disease","volume":"114","author":"Norman","year":"2014","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.01.008_bib91","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1471-4159.2012.07900.x","article-title":"Matrix metalloproteinase-3 in the central nervous system: a look on the bright side","volume":"123","author":"Van Hove","year":"2012","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.01.008_bib92","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3171\/jns.1998.89.3.0431","article-title":"Vascular extracellular matrix remodeling in cerebral aneurysms","volume":"89","author":"Bruno","year":"1998","journal-title":"J. Neurosurg."},{"issue":"11","key":"10.1016\/j.freeradbiomed.2016.01.008_bib93","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1161\/STROKEAHA.110.608257","article-title":"Blood\u2013brain barrier breakdown in acute and chronic cerebrovascular disease","volume":"42","author":"Yang","year":"2011","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.01.008_bib94","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00701-006-0929-8","article-title":"Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMP) in cerebral cavernous malformations: immunohistochemical analysis of MMP-2, -9 and TIMP-2","volume":"149","author":"Fujimura","year":"2007","journal-title":"Acta Neurochir. (Wien)"},{"key":"10.1016\/j.freeradbiomed.2016.01.008_bib95","doi-asserted-by":"crossref","first-page":"D492","DOI":"10.1093\/nar\/gkp858","article-title":"The NCBI bioSystems database","volume":"38","author":"Geer","year":"2010","journal-title":"Nucl. Acids Res."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2016.01.008_bib96","doi-asserted-by":"crossref","first-page":"G907","DOI":"10.1152\/ajpgi.00151.2009","article-title":"Chronic oxidative stress sensitizes hepatocytes to death from 4-hydroxynonenal by JNK\/c-Jun overactivation","volume":"297","author":"Singh","year":"2009","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"6","key":"10.1016\/j.freeradbiomed.2016.01.008_bib97","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1139\/jpn.0261","article-title":"Drug-metabolizing cytochrome P450s in the brain","volume":"27","author":"Miksys","year":"2002","journal-title":"J. Psychiatry Neurosci."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.01.008_bib98","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1124\/dmd.109.029025","article-title":"Gene regulation of CYP4F11 in human keratinocyte HaCaT cells","volume":"38","author":"Wang","year":"2010","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.01.008_bib99","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.abb.2010.11.023","article-title":"Androgen receptor-mediated regulation of the anti-atherogenic enzyme CYP27A1 involves the JNK\/c-jun pathway","volume":"506","author":"Norlin","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2016.01.008_bib100","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/jcp.22951","article-title":"The inflammatory response of keratinocytes and its modulation by vitamin D: the role of MAPK signaling pathways","volume":"227","author":"Miodovnik","year":"2012","journal-title":"J. Cell. Physiol."},{"issue":"5777","key":"10.1016\/j.freeradbiomed.2016.01.008_bib101","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1126\/science.1126431","article-title":"A regulatory SNP causes a human genetic disease by creating a new transcriptional promoter","volume":"312","author":"De Gobbi","year":"2006","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.01.008_bib102","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1182\/blood-2003-02-0419","article-title":"The intronic prothrombin 19911 A>G polymorphism influences splicing efficiency and modulates effects of the 20210G>A polymorphism on mRNA amount and expression in a stable reporter gene assay system","volume":"103","author":"von Ahsen","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.freeradbiomed.2016.01.008_bib103","first-page":"195","article-title":"Intronic microRNA: discovery and biological implications","volume":"26","author":"Li","year":"2007","journal-title":"DNA\u00a0Cell Biol."},{"issue":"D1","key":"10.1016\/j.freeradbiomed.2016.01.008_bib104","doi-asserted-by":"crossref","first-page":"D662","DOI":"10.1093\/nar\/gku1010","article-title":"Ensembl 2015","volume":"43","author":"Cunningham","year":"2015","journal-title":"Nucl. Acids Res."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.01.008_bib105","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10143-013-0456-z","article-title":"Two-hit mechanism in cerebral cavernous malformation? A case of monozygotic twins with a CCM1\/KRIT1 germline mutation","volume":"36","author":"Dammann","year":"2013","journal-title":"Neurosurg. Rev."},{"issue":"9340","key":"10.1016\/j.freeradbiomed.2016.01.008_bib106","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(02)11203-7","article-title":"Clinical importance of the cytochromes P450","volume":"360","author":"Nebert","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.01.008_bib107","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/01.RES.88.1.44","article-title":"Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries","volume":"88","author":"Fleming","year":"2001","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.01.008_bib108","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.pharmthera.2007.09.004","article-title":"Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects","volume":"116","author":"Ingelman-Sundberg","year":"2007","journal-title":"Pharmacol. Ther."},{"issue":"3\u20134","key":"10.1016\/j.freeradbiomed.2016.01.008_bib109","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.plefa.2011.07.004","article-title":"A Promoter polymorphism (rs17222919, -1316T\/G) of ALOX5AP is associated with intracerebral hemorrhage in Korean population","volume":"85","author":"Kim","year":"2011","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"4","key":"10.1016\/j.freeradbiomed.2016.01.008_bib110","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.mehy.2005.09.051","article-title":"Deficiencies in estrogen-mediated regulation of cerebrovascular homeostasis may contribute to an increased risk of cerebral aneurysm pathogenesis and rupture in menopausal and postmenopausal women","volume":"66","author":"Harrod","year":"2006","journal-title":"Med. Hypotheses"},{"issue":"6","key":"10.1016\/j.freeradbiomed.2016.01.008_bib111","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.3171\/jns.2005.103.6.1046","article-title":"Role of estrogen deficiency in the formation and progression of cerebral aneurysms. Part I: experimental study of the effect of oophorectomy in rats","volume":"103","author":"Jamous","year":"2005","journal-title":"J. Neurosurg."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2016.01.008_bib112","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/gerona\/63.5.510","article-title":"Association of blood pressure and genetic background with white matter lesions in patients with mild cognitive impairment","volume":"63","author":"Galluzzi","year":"2008","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.01.008_bib113","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s12031-009-9227-2","article-title":"Cyp46 polymorphisms in Alzheimer\u2019s disease: a review","volume":"39","author":"Garcia","year":"2009","journal-title":"J. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.01.008_bib114","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.abb.2010.11.023","article-title":"Androgen receptor-mediated regulation of the anti-atherogenic enzyme CYP27A1 involves the JNK\/c-jun pathway","volume":"506","author":"Norlin","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"issue":"9","key":"10.1016\/j.freeradbiomed.2016.01.008_bib115","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1194\/jlr.M027680","article-title":"Okadaic acid inhibits the trichostatin A-mediated increase of human CYP46A1 neuronal expression in a ERK1\/2-Sp3-dependent pathway","volume":"53","author":"Nunes","year":"2012","journal-title":"J. Lipid Res."},{"issue":"6","key":"10.1016\/j.freeradbiomed.2016.01.008_bib116","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.chemphyslip.2011.04.002","article-title":"Oxysterols as biomarkers in neurodegenerative diseases","volume":"164","author":"Leoni","year":"2011","journal-title":"Chem. Phys. Lipids"},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.01.008_bib117","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1194\/jlr.R031534","article-title":"Cytochrome P450-mediated metabolism of vitamin D","volume":"55","author":"Jones","year":"2014","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2016.01.008_bib118","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00439-006-0236-8","article-title":"Family-based association study of matrix metalloproteinase-3 and -9 haplotypes with susceptibility to ischemic white matter injury","volume":"120","author":"Fornage","year":"2007","journal-title":"Hum. Genet."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2016.01.008_bib119","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3174\/ajnr.A4200","article-title":"Increased number of white matter lesions in patients with familial cerebral cavernous malformations","volume":"36","author":"Golden","year":"2015","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2016.01.008_bib120","doi-asserted-by":"crossref","first-page":"e425","DOI":"10.1371\/journal.pone.0000425","article-title":"Identification of key processes underlying cancer phenotypes using biologic pathway analysis","volume":"2","author":"Efroni","year":"2007","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.01.008_bib121","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00439-009-0774-y","article-title":"Effects of measured susceptibility genes on cancer risk in family studies","volume":"127","author":"Wu","year":"2010","journal-title":"Hum. Genet."}],"container-title":["Free Radical Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584916000095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584916000095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:31:37Z","timestamp":1760203897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891584916000095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":121,"alternative-id":["S0891584916000095"],"URL":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.01.008","relation":{},"ISSN":["0891-5849"],"issn-type":[{"value":"0891-5849","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1","name":"articletitle","label":"Article Title"},{"value":"Free Radical Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}